US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Belite Bio, Inc.

158.87

-2.1900-1.36%

Pre-market: 156.95-1.9240-1.21%04:00 EDT

Volume:135.34K

Turnover:21.57M

Market Cap:6.40B

PE:-58.02

High:162.39

Open:162.39

Low:157.77

Close:161.06

52wk High:200.00

52wk Low:62.18

Shares:40.27M

Float Shares:19.38M

Volume Ratio:0.99

T/O Rate:0.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7382

EPS(LYR):-2.3141

ROE:-22.10%

ROA:-15.65%

PB:8.24

PE(LYR):-68.65

Loading ...

Overview Company News Filings

Belite Bio Price Target Raised to $214.00/Share from $200.00 by HC Wainwright & Co.

Belite Bio, Inc : H.c. Wainwright Raises Target Price to $214 from $200

THOMSON REUTERS

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease NDA

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

THOMSON REUTERS

Belite Bio - FDA Sets Pdufa Date of February 12, 2027 for Tinlarebant Nda

THOMSON REUTERS

Belite Bio, Inc Expected to Post a Loss of 79 Cents a Share - Earnings Preview

Belite Bio, Inc Expected to Post a Loss of 79 Cents a Share - Earnings Preview

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise

Simply Wall St.

Will Tinlarebant’s First-in-Disease Data and FDA Filing Change Belite Bio’s (BLTE) Narrative?

Simply Wall St.

Belite Bio Announces Oral Presentation at the Asrs Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

THOMSON REUTERS

Belite Bio - Tinlarebant Well Tolerated in Phase 3 Dragon Trial

THOMSON REUTERS

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

Belite Bio Joins H.C. Wainwright Ophthalmology Virtual Conference Panel July 22

Mizuho Securities Sticks to Their Buy Rating for Belite Bio, Inc. ADR (BLTE)

How Phase 3 DRAGON Trial Data Showcases At Major Conferences At Belite Bio (BLTE) Has Changed Its Investment Story

Simply Wall St.

Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium

Belite Bio to Present Phase 3 Dragon Tinlarebant Topline Results at ISCEV Symposium

Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences

Belite Bio CMO Hendrik Peter Scholl reports disposal of ADS worth $1.46 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BLTE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLTE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLTE\",,,,,undefined,":{"symbol":"BLTE","market":"US","secType":"STK","nameCN":"Belite Bio, Inc.","latestPrice":158.87,"timestamp":1787601600000,"preClose":161.06,"halted":0,"volume":135336,"hourTrading":{"tag":"盘前","latestPrice":156.946,"preClose":158.87,"latestTime":"04:00 EDT","volume":8,"amount":1267.73,"timestamp":1787644814411,"change":-1.924,"changeRate":-0.012111,"amplitude":0},"delay":0,"changeRate":-0.013597417111635401,"floatShares":19382800,"shares":40272144,"eps":-2.738223,"marketStatus":"Pre-Mkt","change":-2.19,"latestTime":"08-25 04:16:32 EDT","open":162.385,"high":162.385,"low":157.77,"amount":21569643.26256,"amplitude":0.028654,"askPrice":178.62,"askSize":100,"bidPrice":157,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-2.738223,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1651204800000,"exchange":"NASDAQ","adjPreClose":158.87,"preHourTrading":{"tag":"盘前","latestPrice":156.946,"preClose":158.87,"latestTime":"04:00 EDT","volume":8,"amount":1267.73,"timestamp":1787644814411,"change":-1.924,"changeRate":-0.012111,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":158.87,"preClose":158.87,"latestTime":"19:30 EDT","volume":767,"amount":121847.55,"timestamp":1787614206810,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.99233},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLTE\",,,,,undefined,":{"symbol":"BLTE","floatShares":19382800,"roa":"-15.65%","roe":"-22.10%","lyrEps":-2.31411,"volumeRatio":0.99233,"shares":40272144,"dividePrice":0,"high":162.385,"amplitude":0.028654,"preClose":161.06,"low":157.77,"week52Low":62.18,"pbRate":"8.24","week52High":200,"institutionHeld":0,"latestPrice":158.87,"committee":-0.923077,"eps":-2.738223,"divideRate":0,"volume":135336,"delay":0,"ttmEps":-2.738223,"open":162.385,"prevYearClose":159.96,"prevWeekClose":161.06,"prevMonthClose":158.61,"prevQuarterClose":153.985,"fiveDayClose":163.21,"twentyDayClose":158.43,"sixtyDayClose":148},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLTE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"BLTE","fiscalQuarterEnding":"2026/06","expectedEps":-0.73,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.7},{"market":"US","date":"2026-05-20","symbol":"BLTE","fiscalQuarterEnding":"2026/03","expectedEps":-0.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1779249600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2026-03-31","symbol":"BLTE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2026-03-02","symbol":"BLTE","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2025-11-10","symbol":"BLTE","fiscalQuarterEnding":"2025/09","expectedEps":-0.53,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLTE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLTE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1769659200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLTE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLTE","date":"2026-08-21","current":-58.01938,"percent":0.425234,"low":-172.368683,"twenty":-88.719196,"median":-57.780936,"eighty":-40.067584,"high":-14.956745,"avg":-63.388459,"sd":26.686739,"marketCap":6521670999},"quantilePoints":[{"date":"2022-04-29","current":-26.398656,"twenty":-21.821892,"median":-14.956745,"eighty":-14.956745,"marketCap":255169407},{"date":"2022-05-06","current":-40.308429,"twenty":-35.871261,"median":-27.657515,"eighty":-17.818469,"marketCap":389621275},{"date":"2022-05-13","current":-35.39991,"twenty":-36.668954,"median":-33.652677,"eighty":-23.826095,"marketCap":342175534},{"date":"2022-05-20","current":-32.621429,"twenty":-36.112759,"median":-33.266295,"eighty":-27.405744,"marketCap":315318733},{"date":"2022-05-27","current":-37.380865,"twenty":-36.745988,"median":-34.47375,"eighty":-30.038223,"marketCap":361323438},{"date":"2022-06-03","current":-38.461385,"twenty":-37.850894,"median":-35.39991,"eighty":-31.787884,"marketCap":371767749},{"date":"2022-06-10","current":-47.620083,"twenty":-38.810445,"median":-36.371275,"eighty":-32.168639,"marketCap":460295722},{"date":"2022-06-17","current":-74.555916,"twenty":-40.580208,"median":-36.768666,"eighty":-32.673126,"marketCap":720657483},{"date":"2022-06-24","current":-88.191056,"twenty":-58.528195,"median":-37.792492,"eighty":-32.879912,"marketCap":852454746},{"date":"2022-07-01","current":-96.963853,"twenty":-72.549235,"median":-38.332752,"eighty":-33.599043,"marketCap":937252607},{"date":"2022-07-08","current":-110.573267,"twenty":-77.365269,"median":-38.679547,"eighty":-33.64195,"marketCap":1068801195},{"date":"2022-07-15","current":-108.232139,"twenty":-87.120826,"median":-39.696266,"eighty":-34.309535,"marketCap":1046171854},{"date":"2022-07-22","current":-102.289276,"twenty":-100.472972,"median":-41.278457,"eighty":-34.967702,"marketCap":988728142},{"date":"2022-07-29","current":-86.441642,"twenty":-100.164252,"median":-58.528195,"eighty":-35.338166,"marketCap":835544908},{"date":"2022-08-05","current":-78.131924,"twenty":-97.591584,"median":-71.520167,"eighty":-35.482236,"marketCap":755223180},{"date":"2022-08-12","current":-87.565462,"twenty":-95.543741,"median":-72.600688,"eighty":-36.079095,"marketCap":736075276},{"date":"2022-08-19","current":-66.768665,"twenty":-93.315811,"median":-74.864636,"eighty":-36.460142,"marketCap":561257398},{"date":"2022-08-26","current":-75.643543,"twenty":-91.390849,"median":-75.643543,"eighty":-36.673454,"marketCap":635859622},{"date":"2022-09-02","current":-101.706101,"twenty":-95.030364,"median":-76.279604,"eighty":-36.757327,"marketCap":854941487},{"date":"2022-09-09","current":-114.249262,"twenty":-100.225996,"median":-76.845232,"eighty":-37.135985,"marketCap":960379296},{"date":"2022-09-16","current":-114.811338,"twenty":-102.848828,"median":-77.205764,"eighty":-37.627841,"marketCap":965104104},{"date":"2022-09-23","current":-109.456828,"twenty":-106.174005,"median":-77.716055,"eighty":-37.836293,"marketCap":920094096},{"date":"2022-09-30","current":-99.250718,"twenty":-106.801736,"median":-79.400575,"eighty":-38.068668,"marketCap":834301538},{"date":"2022-10-07","current":-86.234231,"twenty":-106.278454,"median":-80.156097,"eighty":-38.358478,"marketCap":724884943},{"date":"2022-10-14","current":-82.151787,"twenty":-105.832011,"median":-82.151787,"eighty":-38.461385,"marketCap":690567920},{"date":"2022-10-21","current":-90.139177,"twenty":-105.405334,"median":-84.829042,"eighty":-38.72318,"marketCap":757709921},{"date":"2022-10-28","current":-85.139662,"twenty":-104.55188,"median":-85.169245,"eighty":-39.176175,"marketCap":715684002},{"date":"2022-11-04","current":-81.826375,"twenty":-103.869533,"median":-84.873416,"eighty":-39.562487,"marketCap":687832505},{"date":"2022-11-11","current":-74.19398,"twenty":-102.848828,"median":-83.60135,"eighty":-40.063564,"marketCap":623674592},{"date":"2022-11-18","current":-79.873901,"twenty":-102.088608,"median":-82.403242,"eighty":-40.512263,"marketCap":671420016},{"date":"2022-11-25","current":-95.848682,"twenty":-101.855338,"median":-83.409061,"eighty":-41.152396,"marketCap":805704019},{"date":"2022-12-02","current":-98.570311,"twenty":-101.188152,"median":-84.60717,"eighty":-44.193289,"marketCap":828582034},{"date":"2022-12-09","current":-92.062067,"twenty":-100.28774,"median":-85.184037,"eighty":-51.983328,"marketCap":773873736},{"date":"2022-12-16","current":-89.784182,"twenty":-99.761792,"median":-85.790487,"eighty":-61.824383,"marketCap":754725832},{"date":"2022-12-23","current":-91.38166,"twenty":-98.978555,"median":-86.012359,"eighty":-68.360546,"marketCap":768154233},{"date":"2022-12-30","current":-89.177732,"twenty":-98.392813,"median":-86.135345,"eighty":-70.79982,"marketCap":749628014},{"date":"2023-01-06","current":-88.719196,"twenty":-97.682823,"median":-86.204648,"eighty":-71.005634,"marketCap":745773565},{"date":"2023-01-13","current":-84.31134,"twenty":-97.564491,"median":-86.204648,"eighty":-72.034701,"marketCap":708721128},{"date":"2023-01-20","current":-87.535879,"twenty":-97.44616,"median":-86.234231,"eighty":-72.446328,"marketCap":735826602},{"date":"2023-01-27","current":-88.600865,"twenty":-97.085248,"median":-86.657722,"eighty":-72.590397,"marketCap":744778869},{"date":"2023-02-03","current":-88.674822,"twenty":-96.971566,"median":-87.24005,"eighty":-73.875322,"marketCap":745400554},{"date":"2023-02-10","current":-91.706776,"twenty":-96.947371,"median":-87.335437,"eighty":-74.241312,"marketCap":770887161},{"date":"2023-02-17","current":-93.363716,"twenty":-96.947371,"median":-87.496436,"eighty":-74.253145,"marketCap":784815396},{"date":"2023-02-24","current":-94.192038,"twenty":-97.132581,"median":-87.565462,"eighty":-74.434808,"marketCap":791778270},{"date":"2023-03-03","current":-95.22744,"twenty":-97.363328,"median":-87.632615,"eighty":-74.92638,"marketCap":800481863},{"date":"2023-03-10","current":-94.961194,"twenty":-97.42841,"median":-87.920457,"eighty":-75.189222,"marketCap":798243796},{"date":"2023-03-17","current":-84.222592,"twenty":-97.363328,"median":-87.934805,"eighty":-75.466045,"marketCap":707975105},{"date":"2023-03-24","current":-79.903484,"twenty":-97.132581,"median":-87.713377,"eighty":-75.714542,"marketCap":671668690},{"date":"2023-03-31","current":-88.452654,"twenty":-96.979278,"median":-87.632615,"eighty":-75.840972,"marketCap":743533012},{"date":"2023-04-06","current":-57.292558,"twenty":-96.963853,"median":-87.632615,"eighty":-75.761875,"marketCap":724636269},{"date":"2023-04-13","current":-57.666119,"twenty":-96.947371,"median":-87.572858,"eighty":-75.049868,"marketCap":729361076},{"date":"2023-04-21","current":-58.76284,"twenty":-96.780899,"median":-87.496436,"eighty":-73.875322,"marketCap":743232403},{"date":"2023-04-28","current":-56.892666,"twenty":-96.263671,"median":-87.36502,"eighty":-70.954181,"marketCap":719578441},{"date":"2023-05-04","current":-56.842842,"twenty":-95.967014,"median":-87.328799,"eighty":-59.191996,"marketCap":718948267},{"date":"2023-05-12","current":-53.472161,"twenty":-95.706684,"median":-87.269633,"eighty":-58.621736,"marketCap":676315896},{"date":"2023-05-19","current":-31.356182,"twenty":-95.434521,"median":-86.850673,"eighty":-57.749299,"marketCap":579242744},{"date":"2023-05-26","current":-31.817882,"twenty":-95.280689,"median":-86.441642,"eighty":-56.991071,"marketCap":587771741},{"date":"2023-06-02","current":-23.242075,"twenty":-95.24519,"median":-86.204648,"eighty":-56.754266,"marketCap":429350860},{"date":"2023-06-09","current":-20.2105,"twenty":-95.211949,"median":-86.135345,"eighty":-55.086075,"marketCap":373348574},{"date":"2023-06-16","current":-19.595992,"twenty":-95.109539,"median":-85.997567,"eighty":-51.074789,"marketCap":361996759},{"date":"2023-06-23","current":-16.755597,"twenty":-94.98486,"median":-85.790487,"eighty":-40.900274,"marketCap":309526148},{"date":"2023-06-30","current":-20.388025,"twenty":-94.961194,"median":-85.31716,"eighty":-39.361819,"marketCap":376627987},{"date":"2023-07-07","current":-17.916335,"twenty":-94.961194,"median":-85.169245,"eighty":-38.409932,"marketCap":330968465},{"date":"2023-07-14","current":-17.670532,"twenty":-94.842862,"median":-84.784667,"eighty":-37.258425,"marketCap":326427739},{"date":"2023-07-21","current":-21.739944,"twenty":-94.742281,"median":-84.31134,"eighty":-36.079095,"marketCap":401601979},{"date":"2023-07-28","current":-28.062553,"twenty":-94.677198,"median":-83.409061,"eighty":-34.796165,"marketCap":518399540},{"date":"2023-08-04","current":-29.93339,"twenty":-94.286703,"median":-82.536365,"eighty":-32.904256,"marketCap":552959509},{"date":"2023-08-11","current":-26.995861,"twenty":-94.08554,"median":-81.989081,"eighty":-32.668261,"marketCap":618043247},{"date":"2023-08-18","current":-31.292116,"twenty":-93.502756,"median":-80.702223,"eighty":-32.00793,"marketCap":716401699},{"date":"2023-08-25","current":-37.94065,"twenty":-93.221718,"median":-80.156097,"eighty":-32.083886,"marketCap":868613234},{"date":"2023-09-01","current":-40.854587,"twenty":-92.915312,"median":-79.903484,"eighty":-32.320414,"marketCap":935324909},{"date":"2023-09-08","current":-37.500586,"twenty":-92.465023,"median":-79.844318,"eighty":-32.523965,"marketCap":858538410},{"date":"2023-09-15","current":-37.738458,"twenty":-92.121233,"median":-79.42228,"eighty":-32.656553,"marketCap":863984261},{"date":"2023-09-21","current":-36.644245,"twenty":-91.920069,"median":-79.21615,"eighty":-32.731151,"marketCap":838933346},{"date":"2023-09-29","current":-37.881182,"twenty":-91.707013,"median":-77.967511,"eighty":-32.822322,"marketCap":867251771},{"date":"2023-10-06","current":-35.787904,"twenty":-91.647669,"median":-77.231491,"eighty":-32.885998,"marketCap":819328282},{"date":"2023-10-13","current":-37.952543,"twenty":-91.405326,"median":-77.122689,"eighty":-32.951309,"marketCap":868885527},{"date":"2023-10-20","current":-38.475863,"twenty":-91.369827,"median":-76.767694,"eighty":-33.211951,"marketCap":880866399},{"date":"2023-10-27","current":-45.552567,"twenty":-91.34616,"median":-76.665504,"eighty":-33.405497,"marketCap":1042880466},{"date":"2023-11-03","current":-47.146312,"twenty":-91.286994,"median":-75.916538,"eighty":-33.631223,"marketCap":1079367668},{"date":"2023-11-10","current":-46.38512,"twenty":-91.12133,"median":-75.643543,"eighty":-34.145321,"marketCap":1061940945},{"date":"2023-11-17","current":-32.223509,"twenty":-90.866917,"median":-74.864636,"eighty":-33.631223,"marketCap":1012655993},{"date":"2023-11-24","current":-33.118039,"twenty":-90.577004,"median":-74.253145,"eighty":-33.149655,"marketCap":1040767491},{"date":"2023-12-01","current":-36.94712,"twenty":-90.2723,"median":-72.600688,"eighty":-33.116322,"marketCap":1161100195},{"date":"2023-12-08","current":-37.377453,"twenty":-90.227926,"median":-71.520167,"eighty":-33.118039,"marketCap":1174623824},{"date":"2023-12-15","current":-38.791402,"twenty":-90.192426,"median":-66.768665,"eighty":-33.149655,"marketCap":1219058607},{"date":"2023-12-22","current":-39.344687,"twenty":-90.091844,"median":-58.792369,"eighty":-33.34111,"marketCap":1236446131},{"date":"2023-12-29","current":-40.284393,"twenty":-90.020845,"median":-58.76284,"eighty":-33.557154,"marketCap":1265977322},{"date":"2024-01-05","current":-35.752728,"twenty":-89.949846,"median":-58.606145,"eighty":-33.562423,"marketCap":1123565223},{"date":"2024-01-12","current":-40.179005,"twenty":-89.831515,"median":-58.014771,"eighty":-33.5858,"marketCap":1262665413},{"date":"2024-01-19","current":-40.266828,"twenty":-89.713183,"median":-57.705441,"eighty":-33.620497,"marketCap":1265425337},{"date":"2024-01-26","current":-40.38978,"twenty":-89.571185,"median":-57.15493,"eighty":-33.927117,"marketCap":1269289231},{"date":"2024-02-02","current":-39.616938,"twenty":-89.506103,"median":-56.892666,"eighty":-34.392767,"marketCap":1245001896},{"date":"2024-02-09","current":-40.284393,"twenty":-89.381854,"median":-56.610494,"eighty":-34.634958,"marketCap":1265977322},{"date":"2024-02-16","current":-42.155022,"twenty":-89.204356,"median":-56.244496,"eighty":-34.960534,"marketCap":1324763712},{"date":"2024-02-23","current":-41.004541,"twenty":-89.151107,"median":-53.472161,"eighty":-35.087183,"marketCap":1288608702},{"date":"2024-03-01","current":-40.61812,"twenty":-89.015026,"median":-51.278227,"eighty":-35.130626,"marketCap":1276465035},{"date":"2024-03-08","current":-40.907936,"twenty":-88.890777,"median":-47.620083,"eighty":-35.295508,"marketCap":1285572785},{"date":"2024-03-15","current":-34.84258,"twenty":-88.843445,"median":-46.825184,"eighty":-35.130626,"marketCap":1102140477},{"date":"2024-03-22","current":-40.334824,"twenty":-88.748779,"median":-46.658674,"eighty":-35.295508,"marketCap":1275871163},{"date":"2024-03-28","current":-36.796197,"twenty":-88.748779,"median":-46.38512,"eighty":-35.324053,"marketCap":1163937298},{"date":"2024-04-05","current":-35.92997,"twenty":-88.748779,"median":-45.487152,"eighty":-35.288372,"marketCap":1136536821},{"date":"2024-04-12","current":-36.768551,"twenty":-88.719196,"median":-44.612971,"eighty":-35.324053,"marketCap":1163062815},{"date":"2024-04-19","current":-31.884508,"twenty":-88.689613,"median":-42.871015,"eighty":-35.086181,"marketCap":1008570762},{"date":"2024-04-26","current":-35.017668,"twenty":-88.674822,"median":-42.11111,"eighty":-34.84258,"marketCap":1107678872},{"date":"2024-05-03","current":-37.874372,"twenty":-88.630448,"median":-41.895765,"eighty":-34.876769,"marketCap":1198042148},{"date":"2024-05-10","current":-39.164497,"twenty":-88.600865,"median":-41.759818,"eighty":-35.017668,"marketCap":1238851370},{"date":"2024-05-17","current":-37.888556,"twenty":-88.51892,"median":-41.404135,"eighty":-35.036098,"marketCap":1235470034},{"date":"2024-05-24","current":-40.736634,"twenty":-88.45295,"median":-41.099684,"eighty":-35.086181,"marketCap":1328340163},{"date":"2024-05-31","current":-44.726371,"twenty":-88.45295,"median":-41.320704,"eighty":-35.090188,"marketCap":1458437495},{"date":"2024-06-07","current":-44.287787,"twenty":-88.45295,"median":-41.564237,"eighty":-35.150327,"marketCap":1444136167},{"date":"2024-06-14","current":-45.649223,"twenty":-88.452713,"median":-41.812512,"eighty":-35.26372,"marketCap":1488529872},{"date":"2024-06-21","current":-44.315199,"twenty":-88.452654,"median":-41.90876,"eighty":-35.309781,"marketCap":1445030000},{"date":"2024-06-28","current":-41.738521,"twenty":-88.435082,"median":-42.047795,"eighty":-35.338325,"marketCap":1361009699},{"date":"2024-07-05","current":-41.574052,"twenty":-88.330443,"median":-41.895765,"eighty":-35.352156,"marketCap":1355646701},{"date":"2024-07-12","current":-44.918251,"twenty":-88.189315,"median":-42.11111,"eighty":-35.375141,"marketCap":1464694326},{"date":"2024-07-19","current":-45.987298,"twenty":-88.174871,"median":-42.325786,"eighty":-35.420258,"marketCap":1499553812},{"date":"2024-07-26","current":-44.899977,"twenty":-88.109788,"median":-43.584226,"eighty":-35.471595,"marketCap":1464098437},{"date":"2024-08-02","current":-43.520266,"twenty":-88.026956,"median":-43.817224,"eighty":-35.574035,"marketCap":1419108843},{"date":"2024-08-09","current":-42.921494,"twenty":-87.985185,"median":-43.584226,"eighty":-35.680862,"marketCap":1514699523},{"date":"2024-08-16","current":-43.329196,"twenty":-87.937675,"median":-43.549246,"eighty":-35.709608,"marketCap":1529087332},{"date":"2024-08-23","current":-42.427047,"twenty":-87.920457,"median":-43.285824,"eighty":-35.766798,"marketCap":1497250478},{"date":"2024-08-30","current":-42.227533,"twenty":-87.837625,"median":-43.151369,"eighty":-35.840236,"marketCap":1490209636},{"date":"2024-09-06","current":-41.811156,"twenty":-87.704739,"median":-42.818846,"eighty":-35.920981,"marketCap":1475515703},{"date":"2024-09-13","current":-42.348976,"twenty":-87.655158,"median":-42.505117,"eighty":-35.939185,"marketCap":1494495366},{"date":"2024-09-20","current":-42.019345,"twenty":-87.592087,"median":-42.444396,"eighty":-36.002643,"marketCap":1482862669},{"date":"2024-09-27","current":-40.379861,"twenty":-87.577296,"median":-42.418372,"eighty":-36.131858,"marketCap":1425005311},{"date":"2024-10-04","current":-44.231346,"twenty":-87.559545,"median":-42.405361,"eighty":-36.278376,"marketCap":1560924185},{"date":"2024-10-11","current":-47.98741,"twenty":-87.52799,"median":-42.427047,"eighty":-36.500979,"marketCap":1693475699},{"date":"2024-10-18","current":-49.401356,"twenty":-87.4777,"median":-42.496443,"eighty":-36.508509,"marketCap":1743373845},{"date":"2024-10-25","current":-58.032497,"twenty":-87.399798,"median":-42.716197,"eighty":-36.512298,"marketCap":2047966817},{"date":"2024-11-01","current":-60.634851,"twenty":-87.378787,"median":-43.151369,"eighty":-36.539601,"marketCap":2139803894},{"date":"2024-11-08","current":-70.332957,"twenty":-87.33942,"median":-43.285824,"eighty":-36.622431,"marketCap":2482050067},{"date":"2024-11-15","current":-77.408654,"twenty":-87.328799,"median":-43.549246,"eighty":-36.633108,"marketCap":2557117482},{"date":"2024-11-22","current":-74.996937,"twenty":-87.316966,"median":-43.666461,"eighty":-36.650676,"marketCap":2477448806},{"date":"2024-11-29","current":-59.133818,"twenty":-87.269633,"median":-43.967987,"eighty":-36.6764,"marketCap":1953426542},{"date":"2024-12-06","current":-69.51916,"twenty":-87.269633,"median":-44.153275,"eighty":-36.69182,"marketCap":2296495920},{"date":"2024-12-13","current":-58.273826,"twenty":-87.24005,"median":-44.231346,"eighty":-36.709998,"marketCap":1925017556},{"date":"2024-12-20","current":-59.937724,"twenty":-86.853269,"median":-44.309468,"eighty":-36.711971,"marketCap":1979982767},{"date":"2024-12-27","current":-57.956002,"twenty":-86.849115,"median":-44.333473,"eighty":-36.757235,"marketCap":1914518584},{"date":"2025-01-03","current":-58.040132,"twenty":-86.619651,"median":-44.383728,"eighty":-36.76862,"marketCap":1917297723},{"date":"2025-01-10","current":-51.851927,"twenty":-86.457078,"median":-44.443119,"eighty":-36.779678,"marketCap":1712876546},{"date":"2025-01-17","current":-52.54366,"twenty":-86.358678,"median":-44.497942,"eighty":-36.814627,"marketCap":1735727251},{"date":"2025-01-24","current":-55.544285,"twenty":-86.228314,"median":-44.552765,"eighty":-36.851488,"marketCap":1834849907},{"date":"2025-01-31","current":-55.938057,"twenty":-86.204648,"median":-44.601142,"eighty":-36.900103,"marketCap":1847857786},{"date":"2025-02-07","current":-55.446527,"twenty":-86.200593,"median":-44.698959,"eighty":-36.953149,"marketCap":1831620579},{"date":"2025-02-14","current":-53.971937,"twenty":-86.164763,"median":-44.749213,"eighty":-36.980019,"marketCap":1782908960},{"date":"2025-02-21","current":-54.935721,"twenty":-86.086316,"median":-44.854291,"eighty":-36.991032,"marketCap":1814746620},{"date":"2025-02-28","current":-55.128478,"twenty":-86.02715,"median":-44.9548,"eighty":-37.001054,"marketCap":1821114152},{"date":"2025-03-07","current":-60.901548,"twenty":-85.997567,"median":-45.140974,"eighty":-37.048628,"marketCap":2011821735},{"date":"2025-03-14","current":-65.002451,"twenty":-85.849653,"median":-45.320286,"eighty":-37.105201,"marketCap":2147290978},{"date":"2025-03-21","current":-60.090666,"twenty":-85.790487,"median":-45.462383,"eighty":-37.164804,"marketCap":2171917014},{"date":"2025-03-28","current":-59.572643,"twenty":-85.790487,"median":-45.621812,"eighty":-37.191352,"marketCap":2153193592},{"date":"2025-04-04","current":-50.81984,"twenty":-85.31716,"median":-45.720036,"eighty":-37.227032,"marketCap":1836832314},{"date":"2025-04-11","current":-50.551898,"twenty":-85.198828,"median":-45.987298,"eighty":-37.245718,"marketCap":1827147785},{"date":"2025-04-17","current":-50.373269,"twenty":-85.175162,"median":-46.38512,"eighty":-37.351106,"marketCap":1820691433},{"date":"2025-04-25","current":-52.007721,"twenty":-85.145579,"median":-46.700301,"eighty":-37.380183,"marketCap":1879767059},{"date":"2025-05-02","current":-55.964345,"twenty":-84.997664,"median":-46.789503,"eighty":-37.400523,"marketCap":2022775269},{"date":"2025-05-09","current":-54.571041,"twenty":-84.678169,"median":-47.383198,"eighty":-37.411979,"marketCap":1972415719},{"date":"2025-05-16","current":-48.858885,"twenty":-84.512504,"median":-47.693419,"eighty":-37.416587,"marketCap":2078945537},{"date":"2025-05-23","current":-49.033381,"twenty":-84.34684,"median":-48.022108,"eighty":-37.45539,"marketCap":2086370342},{"date":"2025-05-30","current":-50.205396,"twenty":-84.258091,"median":-47.848618,"eighty":-37.472041,"marketCap":2136239621},{"date":"2025-06-06","current":-49.119296,"twenty":-83.849847,"median":-48.100179,"eighty":-37.491071,"marketCap":2090026028},{"date":"2025-06-13","current":-47.528387,"twenty":-83.370603,"median":-47.848618,"eighty":-37.527405,"marketCap":2022332877},{"date":"2025-06-20","current":-46.166937,"twenty":-83.086607,"median":-47.656751,"eighty":-37.54841,"marketCap":1964403162},{"date":"2025-06-27","current":-45.815101,"twenty":-82.749362,"median":-47.146312,"eighty":-37.618944,"marketCap":1949432561},{"date":"2025-07-03","current":-45.482387,"twenty":-82.483116,"median":-47.123012,"eighty":-37.721863,"marketCap":1935275580},{"date":"2025-07-11","current":-47.444253,"twenty":-82.246452,"median":-47.080945,"eighty":-37.741681,"marketCap":2018752951},{"date":"2025-07-18","current":-46.648798,"twenty":-82.086705,"median":-47.138309,"eighty":-37.762158,"marketCap":1984906376},{"date":"2025-07-25","current":-47.306578,"twenty":-81.73171,"median":-47.130661,"eighty":-37.794124,"marketCap":2012894890},{"date":"2025-08-01","current":-49.723535,"twenty":-81.222883,"median":-47.306578,"eighty":-37.81362,"marketCap":2115736407},{"date":"2025-08-08","current":-53.609023,"twenty":-80.631224,"median":-47.45955,"eighty":-37.86727,"marketCap":2281063910},{"date":"2025-08-15","current":-98.849863,"twenty":-82.246452,"median":-47.604873,"eighty":-37.875734,"marketCap":2264848069},{"date":"2025-08-22","current":-93.43304,"twenty":-83.524434,"median":-47.675916,"eighty":-37.881182,"marketCap":2140737810},{"date":"2025-08-29","current":-92.444255,"twenty":-84.583504,"median":-47.98741,"eighty":-37.882657,"marketCap":2118082763},{"date":"2025-09-05","current":-93.347059,"twenty":-85.169245,"median":-48.100179,"eighty":-37.888556,"marketCap":2138767806},{"date":"2025-09-12","current":-98.233664,"twenty":-85.790487,"median":-48.379112,"eighty":-37.928756,"marketCap":2250729707},{"date":"2025-09-19","current":-104.968868,"twenty":-86.086316,"median":-48.559928,"eighty":-37.930737,"marketCap":2405046696},{"date":"2025-09-26","current":-100.325876,"twenty":-86.234231,"median":-48.633609,"eighty":-37.94065,"marketCap":2298666474},{"date":"2025-10-03","current":-106.129616,"twenty":-86.853269,"median":-48.858885,"eighty":-37.946596,"marketCap":2431641752},{"date":"2025-10-10","current":-112.492234,"twenty":-87.328799,"median":-49.053393,"eighty":-37.947556,"marketCap":2577422057},{"date":"2025-10-17","current":-127.639277,"twenty":-87.402756,"median":-49.169943,"eighty":-37.952543,"marketCap":2924471116},{"date":"2025-10-24","current":-132.153297,"twenty":-87.580254,"median":-49.357724,"eighty":-38.059586,"marketCap":3027896332},{"date":"2025-10-31","current":-140.579466,"twenty":-87.920457,"median":-49.578211,"eighty":-38.141512,"marketCap":3220956736},{"date":"2025-11-07","current":-170.145357,"twenty":-88.038789,"median":-49.668864,"eighty":-38.204118,"marketCap":3898370424},{"date":"2025-11-14","current":-62.867205,"twenty":-88.038789,"median":-49.731183,"eighty":-38.297458,"marketCap":3922096298},{"date":"2025-11-21","current":-61.060772,"twenty":-88.009206,"median":-50.085297,"eighty":-38.41346,"marketCap":3809398397},{"date":"2025-11-28","current":-76.865658,"twenty":-87.961164,"median":-50.263812,"eighty":-38.4518,"marketCap":4795417803},{"date":"2025-12-05","current":-84.600321,"twenty":-87.926196,"median":-50.551898,"eighty":-38.461385,"marketCap":5277960208},{"date":"2025-12-12","current":-90.342507,"twenty":-87.926196,"median":-50.817083,"eighty":-38.465443,"marketCap":5636198011},{"date":"2025-12-19","current":-92.928189,"twenty":-88.015123,"median":-51.051465,"eighty":-38.473982,"marketCap":5797510920},{"date":"2025-12-26","current":-93.204797,"twenty":-88.188445,"median":-51.319105,"eighty":-38.482999,"marketCap":5814767650},{"date":"2026-01-02","current":-96.18735,"twenty":-88.452654,"median":-51.851927,"eighty":-38.592579,"marketCap":6000840214},{"date":"2026-01-09","current":-98.619695,"twenty":-88.492532,"median":-52.003264,"eighty":-38.766449,"marketCap":6152586893},{"date":"2026-01-16","current":-89.963675,"twenty":-88.657072,"median":-52.141692,"eighty":-38.800184,"marketCap":5612563794},{"date":"2026-01-23","current":-96.121205,"twenty":-88.742862,"median":-52.291271,"eighty":-38.830228,"marketCap":5996713605},{"date":"2026-01-30","current":-101.635321,"twenty":-88.890777,"median":-52.431964,"eighty":-38.899282,"marketCap":6340722762},{"date":"2026-02-06","current":-107.233622,"twenty":-89.435104,"median":-52.54366,"eighty":-38.907249,"marketCap":6689983967},{"date":"2026-02-13","current":-104.996707,"twenty":-89.762354,"median":-53.057446,"eighty":-38.947409,"marketCap":6550429544},{"date":"2026-02-20","current":-108.099525,"twenty":-90.020845,"median":-53.415891,"eighty":-39.081218,"marketCap":6744005035},{"date":"2026-02-27","current":-113.379125,"twenty":-90.301883,"median":-53.490044,"eighty":-39.142694,"marketCap":7073383486},{"date":"2026-03-06","current":-83.414718,"twenty":-90.301883,"median":-53.860643,"eighty":-39.159746,"marketCap":6473899699},{"date":"2026-03-13","current":-85.942588,"twenty":-90.301883,"median":-54.029764,"eighty":-39.164497,"marketCap":6670090218},{"date":"2026-03-20","current":-80.71659,"twenty":-90.227926,"median":-54.39367,"eighty":-39.237054,"marketCap":6264495230},{"date":"2026-03-27","current":-75.617312,"twenty":-90.227926,"median":-54.422556,"eighty":-39.248948,"marketCap":5868735232},{"date":"2026-04-02","current":-84.77675,"twenty":-90.156927,"median":-54.521294,"eighty":-39.325539,"marketCap":6579608310},{"date":"2026-04-10","current":-91.832608,"twenty":-90.227926,"median":-54.671107,"eighty":-39.358393,"marketCap":7127220553},{"date":"2026-04-17","current":-80.113395,"twenty":-90.156927,"median":-54.889943,"eighty":-39.369191,"marketCap":6217680678},{"date":"2026-04-24","current":-83.357468,"twenty":-90.044511,"median":-54.931528,"eighty":-39.392112,"marketCap":6469456422},{"date":"2026-05-01","current":-80.676039,"twenty":-89.975109,"median":-55.06755,"eighty":-39.425484,"marketCap":6261348033},{"date":"2026-05-08","current":-79.074278,"twenty":-89.914746,"median":-55.152573,"eighty":-39.43251,"marketCap":6137033760},{"date":"2026-05-15","current":-76.007615,"twenty":-89.807848,"median":-55.285556,"eighty":-39.439264,"marketCap":5899027002},{"date":"2026-05-22","current":-62.863227,"twenty":-89.696869,"median":-55.406233,"eighty":-39.581741,"marketCap":5674789230},{"date":"2026-05-29","current":-64.497453,"twenty":-89.634027,"median":-55.586966,"eighty":-39.627477,"marketCap":5822314080},{"date":"2026-06-05","current":-62.954744,"twenty":-89.553435,"median":-55.821442,"eighty":-39.671561,"marketCap":5683050621},{"date":"2026-06-12","current":-59.638354,"twenty":-89.500186,"median":-55.960839,"eighty":-39.711902,"marketCap":5383673526},{"date":"2026-06-18","current":-64.645623,"twenty":-89.381854,"median":-56.058531,"eighty":-39.746916,"marketCap":5835689666},{"date":"2026-06-26","current":-65.294955,"twenty":-89.204356,"median":-56.309501,"eighty":-39.794105,"marketCap":5894306206},{"date":"2026-07-02","current":-62.017787,"twenty":-89.151107,"median":-56.525773,"eighty":-39.809559,"marketCap":5598469707},{"date":"2026-07-10","current":-66.781011,"twenty":-89.015026,"median":-56.867754,"eighty":-39.827989,"marketCap":6028455470},{"date":"2026-07-17","current":-65.661022,"twenty":-88.890777,"median":-56.951724,"eighty":-39.913258,"marketCap":5927351773},{"date":"2026-07-24","current":-68.105824,"twenty":-88.843445,"median":-57.102626,"eighty":-39.964717,"marketCap":6148048948},{"date":"2026-07-31","current":-69.692113,"twenty":-88.748779,"median":-57.367059,"eighty":-39.985795,"marketCap":6291246403},{"date":"2026-08-07","current":-70.018958,"twenty":-88.748779,"median":-57.634318,"eighty":-40.038488,"marketCap":6320751373},{"date":"2026-08-14","current":-63.9038,"twenty":-88.748779,"median":-57.738851,"eighty":-40.047271,"marketCap":6541448548},{"date":"2026-08-21","current":-63.710592,"twenty":-88.719196,"median":-57.780936,"eighty":-40.067584,"marketCap":6521670999}],"updateTime":1787643280868},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLTE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658974717","title":"Belite Bio Price Target Raised to $214.00/Share from $200.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974717?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:46","pubTimestamp":1786535160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLTE/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658558976","title":"Belite Bio, Inc : H.c. Wainwright Raises Target Price to $214 from $200","url":"https://stock-news.laohu8.com/highlight/detail?id=2658558976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658558976?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:12","pubTimestamp":1786529577,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nAZN4TDIE5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948588","title":"Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948588?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:02","pubTimestamp":1786478554,"startTime":"0","endTime":"0","summary":"Belite Bio wins FDA Priority Review for tinlarebant in Stargardt disease NDABelite Bio mendapat penerimaan FDA untuk NDA tinlarebant bagi Stargardt Disease Type 1, disertai Priority Review.Tenggat kep","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL9JHJpn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SG9999014039.USD","BLTE","BK4112","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014005.SGD","BK4585","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","BCDF","LU2210149790.SGD","BK4007","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948355","title":"Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948355","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948355?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:01","pubTimestamp":1786478460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA3V4NQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948311","title":"Belite Bio - FDA Sets Pdufa Date of February 12, 2027 for Tinlarebant Nda","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948311?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:01","pubTimestamp":1786478460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA3V4NQ0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991593","title":"Belite Bio, Inc Expected to Post a Loss of 79 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991593","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658991593?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:33","pubTimestamp":1786455188,"startTime":"0","endTime":"0","summary":"Belite Bio, Inc <BLTE.OQ> expected to post a loss of79cents a share - Earnings PreviewBelite Bio, IncBLTE.OQBLTE.Ois expected to  show no change in quarterly revenue when it reports  results on August","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N4481C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657823647","title":"Belite Bio, Inc Expected to Post a Loss of 79 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657823647","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657823647?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:34","pubTimestamp":1786116883,"startTime":"0","endTime":"0","summary":"Belite Bio, Inc <BLTE.OQ> expected to post a loss of79cents a share - Earnings PreviewBelite Bio, IncBLTE.OQBLTE.Ois expected to  show no change in quarterly revenue when it reports  results on August","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441WG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634858","title":"Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634858","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634858?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:00","pubTimestamp":1786017600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Aug.  06, 2026  (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340178/0/en/Belite-Bio-to-Host-Webcast-on-August-13-2026-to-Discuss-Second-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653353147","title":"3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2653353147","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653353147?lang=en_us&edition=fundamental","pubTime":"2026-07-22 11:30","pubTimestamp":1784691011,"startTime":"0","endTime":"0","summary":"Tariffs on imported generic drugs are set to rise sharply over the next few years, and that kind of policy shock rarely stays contained to one corner of the market. For investors, the question is which U.S. pharmaceutical and biotech manufacturing stocks might stand to benefit if production shifts closer to home, and which could face new pressures through supply chain or pricing risks. This article looks at how the new tariff path could affect larger domestic drug manufacturers and contract...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/3-us-drug-manufacturing-stocks-investors-are-watching-as-tar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/3-us-drug-manufacturing-stocks-investors-are-watching-as-tar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ONC","BK4526","BK4585","BK4007","ISBC","BK4139","BLTE","ADMA","BK4588","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653212425","title":"Will Tinlarebant’s First-in-Disease Data and FDA Filing Change Belite Bio’s (BLTE) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653212425","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653212425?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:20","pubTimestamp":1784553614,"startTime":"0","endTime":"0","summary":"Belite Bio recently presented new data on its oral therapy tinlarebant at multiple ophthalmology conferences, highlighting that it met the primary endpoint of reducing lesion growth in Stargardt disease type 1 and reporting positive secondary endpoint findings, following completion of a New Drug Application submission to the U.S. Food and Drug Administration.\nThe company’s update that tinlarebant is the first therapeutic candidate to show clinical efficacy in Stargardt disease type 1 raises...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blte/belite-bio/news/will-tinlarebants-first-in-disease-data-and-fda-filing-chang","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blte/belite-bio/news/will-tinlarebants-first-in-disease-data-and-fda-filing-chang","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4585","BLTE","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652218775","title":"Belite Bio Announces Oral Presentation at the Asrs Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2652218775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652218775?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:00","pubTimestamp":1784548803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA9CHZ2R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652180452","title":"Belite Bio - Tinlarebant Well Tolerated in Phase 3 Dragon Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2652180452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652180452?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:00","pubTimestamp":1784548803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA9CHZ2R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLTE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652213326","title":"Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2652213326","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652213326?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:00","pubTimestamp":1784548800,"startTime":"0","endTime":"0","summary":"Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease type 1, having met the primary efficacy endpoint, reduction in lesion growth Presentation to includ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/20/3329667/0/en/Belite-Bio-Announces-Oral-Presentation-at-the-ASRS-Annual-Meeting-Featuring-Additional-Positive-Secondary-Endpoint-Data-from-the-Phase-3-Trial-of-Tinlarebant-in-Stargardt-Disease-T.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468556","title":"Belite Bio Joins H.C. Wainwright Ophthalmology Virtual Conference Panel July 22","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468556","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468556?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:03","pubTimestamp":1784117030,"startTime":"0","endTime":"0","summary":"Belite Bio joins H.C. Wainwright ophthalmology virtual conference panel July 22Belite Bio scheduled to join a panel at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL67HYNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","IE00BN0W2T93.GBP","LU2095319765.USD","BK4112","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4007","BLTE","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014021.USD","BCDF","LU0314104364.USD","SG9999014039.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651433891","title":"Mizuho Securities Sticks to Their Buy Rating for Belite Bio, Inc. ADR (BLTE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651433891","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651433891?lang=en_us&edition=fundamental","pubTime":"2026-07-13 23:55","pubTimestamp":1783958110,"startTime":"0","endTime":"0","summary":"In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Belite Bio, Inc. ADR, with a price target of $215.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-belite-bio-inc-adr-blte-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-belite-bio-inc-adr-blte-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DIVL","SAPH","APIE","MFG","CVY","BLTE","DINT","AADR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649957242","title":"How Phase 3 DRAGON Trial Data Showcases At Major Conferences At Belite Bio (BLTE) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2649957242","media":"Simply Wall St.","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649957242?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:27","pubTimestamp":1783481279,"startTime":"0","endTime":"0","summary":"Belite Bio recently announced that Phase 3 DRAGON trial data for its oral retinal therapy tinlarebant in adolescent Stargardt disease were selected for oral presentations at the ISCEV 2026 Symposium in Sydney and the ASRS 2026 Annual Meeting in Montréal.\nThese high‑profile clinical and ophthalmology conferences give external experts a platform to scrutinize and contextualize tinlarebant’s Phase 3 results and regulatory designations, which can shape perceptions of the program’s therapeutic...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blte/belite-bio/news/how-phase-3-dragon-trial-data-showcases-at-major-conferences","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-blte/belite-bio/news/how-phase-3-dragon-trial-data-showcases-at-major-conferences","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649214856","title":"Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2649214856","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649214856?lang=en_us&edition=fundamental","pubTime":"2026-07-06 20:00","pubTimestamp":1783339200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, July  06, 2026  (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/06/3322356/0/en/Belite-Bio-to-Participate-in-the-Piper-Sandler-Virtual-Ophthalmology-Investor-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649625155","title":"Belite Bio to Present Phase 3 Dragon Tinlarebant Topline Results at ISCEV Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2649625155","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649625155?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:00","pubTimestamp":1783335654,"startTime":"0","endTime":"0","summary":"Belite Bio to present Phase 3 DRAGON tinlarebant topline results at ISCEV symposiumBelite Bio scheduled oral presentations of topline Phase 3 DRAGON results for tinlarebant in adolescent Stargardt dis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL19pj0f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999014021.USD","SG9999014039.USD","BK4588","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4112","BK4007","IE00BN0W2V16.EUR","LU2210149790.SGD","BLTE","IE00B64PRP62.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649270626","title":"Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2649270626","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649270626?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:00","pubTimestamp":1783335600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, July  06, 2026  (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/06/3322307/0/en/Belite-Bio-Announces-Oral-Presentations-at-Two-Upcoming-Medical-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645025966","title":"Belite Bio CMO Hendrik Peter Scholl reports disposal of ADS worth $1.46 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2645025966","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645025966?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:06","pubTimestamp":1782122788,"startTime":"0","endTime":"0","summary":"shares by Chief Medical Officer Hendrik Peter Scholl on June 18, 2026.The transactions covered 10,000 American depositary shares sold at prices ranging from USD 143.90 to USD 147.11.Holdings reported indirectly through Bioptima Ltd. fell to 15,000 American depositary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL55TZG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio CMO Hendrik Peter Scholl reports disposal of ADS worth $1.46 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLTE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":128,"code":"91000000","status":"200"}]}}